Stock UniverseDerived research view · source repositories remain read-only

Axsome Therapeutics, Inc. (AXSM)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
40.55
Global Rank
351
Market Cap
8.38B
Latest Close
232.32
RS Composite
35.32% · G#237

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
4.35%
3M
43.12%
6M
57.17%
1Y
114.83%
3Y
214.88%
5Y
282.67%
10Y
2859.49%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 973.24K · 30-day average: 841.40K · Max drawdown over stored range: -81.26%

Research Snapshot

Relative Strength vs SPX

RS Composite35.32%
20D RS4.86%
60D RS36.68%
120D RS49.19%
Global RS Rank237 · 92.94% percentile
Qualified+ RS Rank101 · 91.97% percentile
Group ScopeQualified+
Primary RS Rank39 · 91.48% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank32 / 701
Primary Percentile95.58
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-04708.24Mn/a-173.14M-188.30M-3.74-189.90M952.00K-190.85M50Mn/a-24.45%-26.59%-26.81%-26.95%305.11M117.85M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-3.74-62.1x$14.0716.5x$-3.79-61.3x$-3.77-61.6x

Shares Diluted: 50M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0050.037270.6385.693638.496
Revenue Growth (YoY)3000%3000%3000%440.8%42.533%65.545%
Gross Profit0045.939244.535352.39591.018
Operating Income-99.0877-124.707-175.401-182.907-252.438-169.235
Free Cash Flow-78.5025-108.534-117.213-145.662-128.68-93.885
Free Cash Flow Per Share-2.11-2.885-2.883-3.207-2.686-1.887
EPS (Diluted) GAAP-2.76563-3.47-4.602869-5.266634-5.994374-3.682098
EPS Growth
EPS Non-GAAP
Gross Margin3000%3000%91.81%90.368%91.365%92.564%
Operating Margin3000%3000%-350.543%-67.593%-65.451%-26.505%
Profit Margin3000%3000%-373.991%-88.41%-74.468%-28.688%
Free Cash Flow Margin3000%3000%-234.253%-53.829%-33.363%-14.704%
Shares Outstanding (Diluted)37.206937.618640.655945.425247.914349.7472
Shares Change (YoY)9.367%1.106%8.074%11.731%5.479%3.825%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-04191.20Mn/a-63.36M-33.14%-64.54M-33.76%-1.2651.20M305.11M117.85Mprocessed
2025 Q42026-02-23196.00Mn/a-26.96M-13.75%-28.56M-14.57%-0.5650.64M322.93M117.75Mprocessed
2025 Q32025-11-03170.99Mn/a-46.11M-26.97%-47.23M-27.62%-0.9450.02M325.27M117.64Mprocessed
2025 Q22025-08-04150.04Mn/a-36.71M-24.47%-47.97M-31.97%-0.9749.44M303.02M117.54Mprocessed
2025 Q12025-05-05121.46Mn/a-56.98M-46.91%-59.41M-48.91%-1.2248.87M300.91M181.38Mprocessed
2024 Q42025-02-18118.77Mn/a-72.62M-61.14%-74.91M-63.08%-1.5448.55M315.35M180.71Mprocessed
2024 Q32024-11-12104.76Mn/a-62.62M-59.78%-64.60M-61.67%-1.3448.14M327.34M180.00Mprocessed
2024 Q22024-08-0587.17Mn/a-78.05M-89.54%-79.34M-91.03%-1.6747.57M315.66M179.33Mprocessed
2024 Q12024-05-0675.00Mn/a-67.28M-89.70%-68.36M-91.14%-1.4447.39M331.44M178.69Mprocessed
2023 Q42024-02-2371.53Mn/a-98.27M-1.37%-98.65M-1.38%-2.0847.35M386.19M178.07Mprocessed
2023 Q32023-11-0657.79Mn/a-62.12M-1.07%-62.20M-1.08%-1.3247.12M416.56M177.45Mprocessed
2023 Q22023-08-0746.70Mn/a-65.06M-1.39%-67.17M-1.44%-1.5443.67M437.11M176.82Mprocessed
2023 Q12023-05-0994.58Mn/a-6.37M-6.74%-11.22M-11.86%-0.2643.52M246.51M147.62Mprocessed
2022 Q42023-02-2824.37Mn/a-59.92M-2.46%-61.24M-2.51%-1.4143.48M200.84M94.26Mprocessed
2022 Q32022-11-0716.85Mn/a-42.41M-2.52%-44.82M-2.66%-1.0741.70M227.52M93.91Mprocessed
2022 Q22022-08-098.82Mn/a-39.18M-4.44%-41.44M-4.70%-1.0639.08M73.39M93.46Mprocessed
2022 Q12022-05-02n/an/a-38.29Mn/a-39.63Mn/an/an/a84.71M49.31Mprocessed
2021 Q42022-03-01n/an/a-32.61Mn/a-33.98Mn/an/an/a86.47M49.09Mprocessed
2021 Q32021-11-08n/an/a-33.41Mn/a-34.88Mn/an/an/a114.62M49.17Mprocessed
2021 Q22021-08-09n/an/a-30.85Mn/a-32.28Mn/an/an/a141.22M48.88Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.